Brasofensine
Chemical compound / From Wikipedia, the free encyclopedia
Brasofensine (NS-2214, BMS-204756) is a phenyltropane dopamine reuptake inhibitor that had been under development by Bristol-Myers Squibb and defunct company NeuroSearch for the treatment of Parkinson's and Alzheimer's diseases.
Quick Facts Clinical data, ATC code ...
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H20Cl2N2O |
Molar mass | 327.25 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close